H.C. Wainwright Investment Conference
H.C. Wainwright Investment Conference
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases.
I’ve written about Hemogenyx before, especially into the run up to and during the Great Covid-19 stocks rally of 2020.